Skip to content
Submission sprint intake

Tell us what is missing before FDA does.

Start with a structured readiness intake. We use the first pass to understand the product, submission pathway, available evidence, FDA pressure, and the deliverable your team needs.

AI assists evidence mapping and source coverage checks.
Human DSRV quality/regulatory review controls interpretation.
No approval guarantees, no replacement of sponsor responsibility.
Start structured intakeReview sprint deliverables
Intake blueprint

What DSRV needs first

No upload yet

Client and urgency

Company / team / rolePrimary contactConfidentiality expectationsTarget date or decision pressure

Product profile

Product type or modalityDosage form / device / diagnostic contextDevelopment or commercial stageManufacturing and site context

Submission request

IND / IDE / NDA / ANDA / BLA / supplement / 510(k) / De Novo / IR / CRLCurrent FDA interaction statusSpecific stuck point or review riskDesired sprint deliverable

Evidence available

FDA correspondenceCMC or quality sectionsStability dataAnalytical validation / method lifecycle recordsManufacturing records, deviations, CAPA, OOS/OOT, SOPs
Next backend phase: persist these objects as client, product, submission request, evidence inventory, gap finding, deliverable, and closeout records. This starter page keeps the intake model visible before we add storage, uploads, RAG, or payment.
Phase 2 backend intake

Submit the readiness context DSRV needs to triage fit.

This creates a structured review record for DSRV. Keep source documents out of this form; controlled evidence intake comes after confidentiality and scope are confirmed.

No document uploads in this phase. DSRV will confirm confidentiality and controlled intake before source files are requested.